Patient Engagement Solutions Market

Patient Engagement Solutions Market Size, Growth by Component (Software, Services), Delivery (On-Premise, Cloud), Therapy Area (CVD, Diabetes, Obesity, Fitness), Functionality (E-prescribing, Virtual care), End User (Provider, Payer, Patients) - Global Forecasts to 2027

Report Code: HIT 2767 May, 2022, by marketsandmarkets.com

The global patient engagement solutions market size is projected to reach USD 27.9 billion by 2027, at a CAGR of 10.0%. The factors driving the growth of this market are implementation of changing government regulations and healthcare initiatives to promote patient-centric care, high demand for patient engagement solutions in the post pandemic era, and the growing utilization of m-health apps.However, interoperability for patient engagement solutions and a shortage of skilled IT professionals in the healthcare industry are expected to restrain the growth of this market during the forecast period.

Patient Engagement Solutions Market

To know about the assumptions considered for the study, Request for Free Sample Report

Patient Engagement Solutions Market Dynamics

Drivers: Implementation of government regulations and initiatives to promote patient-centric care

In March 2020, the US President signed a USD 2 million coronavirus emergency stimulus package called the CARES (Coronavirus Aid, Relief, and Economic Security) Act. The law expands cover treatment and services for those affected by COVID-19. The CARES Act also increases flexibility for Medicare to cover telehealth services; authorizes Medicare certification for home health services by physician assistants, nurse practitioners, and certified nurse specialists; and increases Medicare payments for COVID-19-related hospital stays and durable medical equipment. Such initiatives/regulations are expected to increase further the demand and adoption of patient engagement solutions in major markets worldwide.

Restraints: Large investment requirements for healthcare infrastructure

Payers have made substantial investments in infrastructure and proprietary systems in the past. Moving or integrating these systems with patient engagement solutions will pose various challenges to these organizations in terms of cost. It will also require changes to their current systems that are optimized to handle only their current requirements. Also, the move to cloud-based patient engagement solutions would involve changing the current IT architecture, especially in hospitals that already serve as hubs connecting multiple physicians, labs, and pharmacists. Hence, finding the resources to achieve large-scale interoperability and interconnectivity could hamper the transition to cloud-based patient engagement solutions for such healthcare institutions.

Challenges: High deployments costs of healthcare IT systems

Healthcare IT systems have high-priced software solutions.The maintenance and software update costs of these systems may be more than the software price. Support and maintenance services along with software upgrades , represent a recurring expenditure, which amounts to almost 30% of the total cost of ownership. The lack of internal skilled  IT professionals  in the healthcare industry necessitates training for end users to increase the efficiency and results of various healthcare IT solutions, thereby adding to the cost of ownership of the systems. Evaluating information systems in healthcare can also be challenging as the organizational impact & benefits of IT systems in healthcare are often intangible.

Opportunities: Growth opportunities in emerging markets

Several factors, such as adopting  government initiatives that  support the adoption of HCIT solutions, rising government expenditure on healthcare facilities, and the presence of skilled IT experts in emerging Asian countries, such as China and India, are expected to support the growth of the global market in the APAC region. Technological advancements play a key role in reforming the country’s healthcare management sector. China is currently facing challenges such as underfunded rural health centers, overburdened city hospitals, and a nationwide shortage of doctors.

North America accounted for the largest share of the global patient engagement solutions market.

North America accounted for the largest share of the global market. Government regulations supporting the healthcare system, the need to reduce healthcare costs for better accessibility, the rising prevalence of chronic diseases, and the majority of

Key Market Players operating in the region are the key factors driving the growth of the market in North America.

Patient Engagement Solutions Market by Region

To know about the assumptions considered for the study, download the pdf brochure

Some of the key players operating in this market are IBM (US), McKesson Corporation (US), Allscripts (US), Cerner Corporation (US), Epic Systems Corporation (US), Orion Health (New Zealand), GetWellNetwork (US), athenahealth (US), Oneview Healthcare (Ireland), MEDITECH (US), IQVIA (US), Get Real Health (US), Cognizant (US), Symphony Care (US), Harris Healthcare (US), Kareo (US), CureMD Healthcare (US), eClinicalWorks (US), and Lincor Solutions (US), AdvancedMD (US), WellStack(US), IQVIA (US), Vivify Health (US), Medhost (US), Validic (US) MEDISYSINC (US), and  Patient point LLC (US)

Patient Engagement Solutions Market Scope

Report Metrics

Details

Market Size value 2027

USD 27.9 billion

Growth Rate

10.0% CAGR

Largest Market

North America

Market Dynamics

Drivers, Opportunities, Restraints & Challenges

Largest Share Segments

Services, The On-premise solutions, Health Management, Chronic diseases among the therapeutic areas to account, The E- Prescribing, Providers

Forecasts up to

2027

Market Segmentation

Component, Delivery Mode, Therapeutic Area, Application, Functionality, End User, And Region

Patient Engagement Solutions Market Growth Drivers

  • Implementation of government regulations and initiatives to promote patient-centric care
  • Increasing adoption of patient engagement solutions
  • Rising number of collaborations and partnerships between stakeholders
  • Increasing utilization of mobile health apps

Patient Engagement Solutions Market Growth Opportunities

  • Growth opportunities in emerging markets
  • Wearable health technology
  • Cloud-computing solutions

Report Highlights

  • Updated financial information/ product portfolio of players
  • Updated market developments of profiled players

Geographies covered

North America (US, and Canada), Europe (Germany, France, UK, Italy, Spain, and the RoE), Asia Pacific (Japan, China, India, and RoAPAC), RoW (Latin America and Middle East & Africa)

The study categorizes the global patient engagement solutions market size into the following segments and subsegments:

By Component

  • Hardware
  • Software
  • Standalone Software
  • Integrated Software
  • Services

By Delivery Mode

  • PREMISE Mode
  • CLOUD-BASED Mode

By Application

  • Health management
  • Home health management
  • Social
  • Financial health management

By Therapeutic Area

  • Chronic diseases
  • Cardiovascular diseases (CVD)
  • Diabetes
  • Obesity
  • Other chronic diseases
  • Women’s health
  • Fitness
  • Other Therapeutic Areas

By Funtionality

  • Introduction
  • E-Prescribing
  • Virtual Consultation
  • Patient/Client Scheduling
  • Document Management

By End User

  • Providers
  • Payers 
  • Patients
  • Other End users

By Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Rest of Asia Pacific
  • ROW
    • Latin America
    • Middle East & Africa

Recent Developments

:
  • In 2021, McKesson (US) announced a strategic agreement with Merck (US) that enables the two healthcare leaders to harness the power of real-world evidence (RWE) toward the common goal of improving patient outcomes and the quality of cancer care.
  • In 2021, Humana (US) collaborated with IBM (US) to deploy IBM Watson Assistant for Health Benefits; it is an AI-enabled virtual agent built in the IBM Watson Health Cloud. This agent helps provide a better member experience while providing greater clarity and transparency on benefits and other related matters for Humana Employer Group members.
  • In 2021, Allied Digestive Health (ADH) selected athenahealth’s (US) cloud-based healthcare payments and patient engagement solutions to drive patient relations and revenue cycle excellence, thus supporting the organization’s growth in the coming years.

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 27)
    1.1 OBJECTIVES OF THE STUDY
    1.2 MARKET DEFINITION
           1.2.1 PATIENT ENGAGEMENT SOLUTIONS MARKET: INCLUSIONS & EXCLUSIONS
    1.3 MARKET SCOPE
           1.3.1 MARKETS COVERED
           1.3.2 YEARS CONSIDERED FOR THE STUDY
    1.4 CURRENCY
    1.5 LIMITATIONS
           1.5.1 SCOPE-RELATED LIMITATIONS
           1.5.2 METHODOLOGY-RELATED LIMITATIONS
    1.6 STAKEHOLDERS
    1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY (Page No. - 32)
    2.1 RESEARCH DATA
           FIGURE 1 RESEARCH DESIGN
           2.1.1 SECONDARY DATA
                    2.1.1.1 Key data from secondary sources
           2.1.2 PRIMARY RESEARCH
    2.2 PRIMARY SOURCES
           2.2.1 KEY INDUSTRY INSIGHTS
           2.2.2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
    2.3 MARKET SIZE ESTIMATION METHODOLOGY
           FIGURE 2 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
    2.4 MARKET ESTIMATION
           2.4.1 RESEARCH METHODOLOGY: MARKET ESTIMATION
           2.4.2 APPROACH: END USER-BASED MARKET ESTIMATION
                    FIGURE 3 RESEARCH METHODOLOGY: MARKET ESTIMATION
           2.4.3 TOP-DOWN APPROACH: CONTRIBUTION-BASED MARKET SIZE ESTIMATION
           2.4.4 GLOBAL MARKET: TOP-DOWN APPROACH
           2.4.5 GROWTH FORECAST
                    FIGURE 4 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN THE LABORATORY INFORMATICS MARKET (2022–2027)
           FIGURE 5 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
    2.5 MARKET DATA ESTIMATION AND TRIANGULATION
           FIGURE 6 DATA TRIANGULATION METHODOLOGY
    2.6 ASSUMPTIONS FOR THE STUDY
    2.7 RISK ASSESSMENT
           TABLE 1 RISK ASSESSMENT: GLOBAL MARKET
    2.8 LIMITATIONS

3 EXECUTIVE SUMMARY (Page No. - 45)
    FIGURE 7 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2022 VS. 2027
    FIGURE 8 GLOBAL MARKET, BY DELIVERY MODE, 2022 VS. 2027
    FIGURE 9 GLOBAL MARKET, BY APPLICATION, 2022 VS. 2027
    FIGURE 10 GLOBAL MARKET, BY THERAPEUTIC AREA, 2022 VS. 2027
    FIGURE 11 GLOBAL MARKET, BY FUNCTIONALITY, 2022 VS. 2027
    FIGURE 12 GLOBAL MARKET, BY END USER, 2022 VS. 2027
    FIGURE 13 GEOGRAPHICAL SNAPSHOT OF THE GLOBAL MARKET

4 PREMIUM INSIGHTS (Page No. - 51)
    4.1 GLOBAL MARKET OVERVIEW
           FIGURE 14 RISING GOVERNMENT INITIATIVES FOR PATIENT-CENTRIC CARE DRIVE THE MARKET GROWTH
    4.2 GLOBAL MARKET, BY END USER
           FIGURE 15 PROVIDERS ACCOUNTED FOR THE LARGEST SHARE OF THE GLOBAL MARKET IN 2021
    4.3 NORTH AMERICA: MARKET, BY DELIVERY MODE & COUNTRY (2021)
           FIGURE 16 ON-PREMISE SOLUTIONS ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN MARKET IN 2021
    4.4 GEOGRAPHICAL SNAPSHOT OF THE GLOBAL MARKET
           FIGURE 17 ASIA PACIFIC MARKET TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD

5 MARKET OVERVIEW (Page No. - 55)
    5.1 INTRODUCTION
    5.2 Market Dynamics


           FIGURE 18 GLOBAL MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
           5.2.1 DRIVERS
                    5.2.1.1 Implementation of government regulations and initiatives to promote patient-centric care
                    5.2.1.2 Increasing adoption of patient engagement solutions
                    5.2.1.3 Rising number of collaborations and partnerships between stakeholders
                               TABLE 2 INDICATIVE LIST OF COLLABORATIONS BETWEEN ORGANIZATIONS FROM 2020 TO 2022
                    5.2.1.4 Increasing utilization of mobile health apps
           5.2.2 RESTRAINTS
                    5.2.2.1 Large investment requirements for healthcare infrastructure
                    5.2.2.2 Protection of patient information
                    5.2.2.3 Inadequate interoperability across healthcare providers
                    5.2.2.4 Shortage of skilled IT professionals in the healthcare industry
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Growth opportunities in emerging markets
                    5.2.3.2 Wearable health technology
                    5.2.3.3 Cloud-computing solutions
           5.2.4 CHALLENGES
                    5.2.4.1 High deployments costs of healthcare IT systems
                    5.2.4.2 Low levels of healthcare literacy
    5.3 IMPACT OF COVID-19 ON THE GLOBAL MARKET
    5.4 CASE STUDIES
           5.4.1 FOCUS ON REDUCING READMISSION RATES AND IMPROVING CARE
                    5.4.1.1 Case 1: Need to reduce patient hospital stays
           5.4.2 IMPROVE OUTPATIENT COMMUNICATION
                    5.4.2.1 Case 2: Rising need to curb miscommunication with discharged patients
           5.4.3 PATIENT ENGAGEMENT STRATEGY
                    5.4.3.1 Case 3: Post-discharge care
    5.5 ECOSYSTEM ANALYSIS
           FIGURE 19 GLOBAL MARKET: ECOSYSTEM ANALYSIS
    5.6 TECHNOLOGY ANALYSIS
           TABLE 3 TECHNOLOGICAL DEVELOPMENTS BY LEADING VENDORS
    5.7 REGULATORY ANALYSIS
           5.7.1 HEALTH INSURANCE PORTABILITY AND ACCOUNTABILITY ACT OF 1996 (HIPAA)
           5.7.2 HEALTH INFORMATION TECHNOLOGY FOR ECONOMIC AND CLINICAL HEALTH ACT OF 2009 (HITECH)
           5.7.3 CONSUMER PRIVACY PROTECTION ACT OF 2017
           5.7.4 NATIONAL CYBERSECURITY PROTECTION ADVANCEMENT ACT OF 2015
           5.7.5 CYBERSECURITY LAW OF THE PEOPLE’S REPUBLIC OF CHINA
           5.7.6 AFFORDABLE CARE ACT, 2010
    5.8 PRICING ANALYSIS
    5.9 PORTER’S FIVE FORCES ANALYSIS
           TABLE 4 PATIENT ENGAGEMENT SOLUTION MARKET: PORTER’S FIVE FORCES ANALYSIS
    5.10 INDUSTRY TRENDS
           5.10.1 RISING NEED FOR INTEROPERABILITY & INTEGRATION OF HCIT SOLUTIONS
           5.10.2 GRADUAL SHIFT OF ACCOUNTABILITY FROM PAYERS TO PROVIDERS
           5.10.3 GROWING DEMAND FOR VALUE-BASED HEALTHCARE

6 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT (Page No. - 70)
    6.1 INTRODUCTION
           TABLE 5 GLOBAL MARKET, BY COMPONENT, 2020–2027
    6.2 HARDWARE
           6.2.1 HARDWARE SOLUTIONS ARE AN INTERACTIVE EXPERIENCE FOR PATIENTS & FAMILIES
                    TABLE 6 HARDWARE MARKET, BY REGION, 2020–2027
    6.3 SOFTWARE
           TABLE 7 SOFTWARE MARKET, BY REGION, 2020–2027
           TABLE 8 SOFTWARE MARKET, BY TYPE, 2020–2027
           6.3.1 STANDALONE SOFTWARE
                    6.3.1.1 Standalone software refers to the traditional software installed in client systems
                               TABLE 9 STANDALONE SOFTWARE MARKET, BY REGION, 2020–2027
           6.3.2 INTEGRATED SOFTWARE
                    6.3.2.1 Reduction in time spent on data management is driving the growth of this segment
                               TABLE 10 INTEGRATED SOFTWARE MARKET, BY REGION, 2020–2027
    6.4 SERVICES
           6.4.1 THE SERVICES SEGMENT IS EXPECTED TO WITNESS THE HIGHEST GROWTH IN THE FORECAST PERIOD
                    TABLE 11 SERVICES MARKET, BY REGION, 2020–2027

7 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE (Page No. - 76)
    7.1 INTRODUCTION
           TABLE 12 GLOBAL MARKET, BY DELIVERY MODE, 2020–2027
    7.2 ON-PREMISE MODE
           7.2.1 PATIENT DATA SAFETY AND COST BENEFITS OF ON-PREMISE DELIVERY MODES TO DRIVE THE MARKET GROWTH
                    TABLE 13 ON-PREMISE MODE MARKET, BY REGION, 2020–2027
    7.3 CLOUD-BASED MODE
           7.3.1 REGULATORY REQUIREMENTS HAVE DRIVEN HEALTHCARE PROVIDERS TO ADOPT CLOUD-BASED SOLUTIONS
                    TABLE 14 CLOUD-BASED MODE MARKET, BY REGION, 2020–2027

8 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION (Page No. - 80)
    8.1 INTRODUCTION
           TABLE 15 GLOBAL MARKET, BY APPLICATION, 2020–2027
    8.2 HEALTH MANAGEMENT
           8.2.1 HEALTH MANAGEMENT PLAYS A CRUCIAL TOOL IN GUIDING PATIENTS IN SELF-CARE
                    TABLE 16 GLOBAL MARKET FOR HEALTH MANAGEMENT, BY REGION, 2020–2027
    8.3 HOME HEALTH MANAGEMENT
           8.3.1 GROWING PREFERENCE FOR HOME HEALTHCARE TO SUPPORT THE MARKET GROWTH
                    TABLE 17 GLOBAL MARKET FOR HOME HEALTH MANAGEMENT, BY REGION, 2020–2027
    8.4 SOCIAL & BEHAVIORAL MANAGEMENT
           8.4.1 GROWING POPULARITY OF SOCIAL MEDIA TO DRIVE THE MARKET GROWTH
                    TABLE 18 GLOBAL MARKET FOR SOCIAL & BEHAVIORAL MANAGEMENT, BY REGION, 2020–2027
    8.5 FINANCIAL HEALTH MANAGEMENT
           8.5.1 FINANCIAL ENGAGEMENT SOLUTIONS HELP PROVIDERS MANAGE PATIENT PAYMENTS
                    TABLE 19 GLOBAL MARKET FOR FINANCIAL HEALTH MANAGEMENT, BY REGION, 2020–2027

9 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA (Page No. - 85)
    9.1 INTRODUCTION
           TABLE 20 GLOBAL MARKET, BY THERAPEUTIC AREA, 2020–2027
    9.2 CHRONIC DISEASES
           TABLE 21 GLOBAL MARKET FOR CHRONIC DISEASES, BY REGION, 2020–2027
           TABLE 22 GLOBAL MARKET FOR CHRONIC DISEASES, BY TYPE, 2020–2027
           9.2.1 CARDIOVASCULAR DISEASES (CVD)
                    9.2.1.1 CVD is the leading cause of death worldwide
                               TABLE 23 GLOBAL MARKET FOR CVD, BY REGION, 2020–2027
           9.2.2 DIABETES
                    9.2.2.1 The high incidence of diabetes worldwide drives the growth of this segment
                               TABLE 24 GLOBAL MARKET FOR DIABETES, BY REGION, 2020–2027
           9.2.3 OBESITY
                    9.2.3.1 Rising prevalence of obesity to drive the growth of this segment
                               TABLE 25 GLOBAL MARKET FOR OBESITY, BY REGION, 2020–2027
           9.2.4 OTHER CHRONIC DISEASES
                    TABLE 26 GLOBAL MARKET FOR OTHER CHRONIC DISEASES, BY REGION, 2020–2027
    9.3 WOMEN’S HEALTH
           9.3.1 INCREASING SELF AWARENESS FOR THE MANAGEMENT OF DISEASES TO DRIVE THE MARKET GROWTH
                    TABLE 27 GLOBAL MARKET FOR WOMEN’S HEALTH, BY REGION, 2020–2027
    9.4 FITNESS
           9.4.1 GROWING PREFERENCE FOR A HEALTHY LIFESTYLE TO SUPPORT THE MARKET GROWTH FOR FITNESS-RELATED APPS
                    TABLE 28 GLOBAL MARKET FOR FITNESS, BY REGION, 2020–2027
    9.5 OTHER THERAPEUTIC AREAS
           TABLE 29 GLOBAL MARKET FOR OTHER THERAPEUTIC AREAS, BY REGION, 2020–2027

10 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY (Page No. - 93)
     10.1 INTRODUCTION
           TABLE 30 GLOBAL MARKET, BY FUNCTIONALITY, 2020–2027
             10.1.1 E-PRESCRIBING
                        10.1.1.1 E-prescribing is a cost-effective method of providing valuable information to clinicians to enhance decision-making
                                     TABLE 31 GLOBAL MARKET FOR E-PRESCRIBING, BY REGION, 2020–2027
             10.1.2 VIRTUAL CONSULTATION
                        10.1.2.1 Telehealth provides flexibility in treatment options due to remote monitoring
                                     TABLE 32 GLOBAL MARKET FOR VIRTUAL CONSULTATION, BY REGION, 2020–2027
             10.1.3 PATIENT/CLIENT SCHEDULING
                        10.1.3.1 Patient/client scheduling enables physicians to streamline workflows and efficiently manage patient schedules
                                     TABLE 33 GLOBAL MARKET FOR PATIENT/CLIENT SCHEDULING, BY REGION, 2020–2027
             10.1.4 DOCUMENT MANAGEMENT
                        10.1.4.1 The effective management of patient documents is crucial for healthcare providers
                                     TABLE 34 GLOBAL MARKET FOR DOCUMENT MANAGEMENT, BY REGION, 2020–2027

11 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER (Page No. - 98)
     11.1 INTRODUCTION
           TABLE 35 GLOBAL MARKET, BY END USER, 2020–2027
     11.2 PROVIDERS
             11.2.1 PROVIDERS ARE THE LARGEST END USERS OF PATIENT ENGAGEMENT SOLUTIONS
                        TABLE 36 GLOBAL MARKET FOR PROVIDERS, BY REGION, 2020–2027
     11.3 PAYERS
             11.3.1 PATIENT ENGAGEMENT SOLUTIONS HELP HEALTHCARE PAYERS MINIMIZE ERRORS
                        TABLE 37 GLOBAL MARKET FOR PAYERS, BY REGION, 2020–2027
     11.4 PATIENTS
             11.4.1 PATIENT ENGAGEMENT SOLUTIONS MOTIVATE INDIVIDUALS TO MONITOR & IMPROVE HEALTH OUTCOMES
                        TABLE 38 GLOBAL MARKET FOR PATIENTS, BY REGION, 2020–2027
     11.5 OTHER END USERS
           TABLE 39 GLOBAL MARKET FOR OTHER END USERS, BY REGION, 2020–2027

12 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY REGION (Page No. - 103)
     12.1 INTRODUCTION
             TABLE 40 GLOBAL MARKET, BY REGION, 2020–2027
     12.2 NORTH AMERICA
             FIGURE 20 NORTH AMERICA: MARKET SNAPSHOT
             TABLE 41 NORTH AMERICA: MARKET, BY COUNTRY, 2020–2027
             TABLE 42 NORTH AMERICA: MARKET, BY COMPONENT, 2020–2027
             TABLE 43 NORTH AMERICA: MARKET, BY DELIVERY MODE, 2020–2027
             TABLE 44 NORTH AMERICA: MARKET, BY END USER, 2020–2027
             TABLE 45 NORTH AMERICA: MARKET, BY APPLICATION, 2020–2027
             TABLE 46 NORTH AMERICA: MARKET, BY THERAPEUTIC AREA, 2020–2027
             TABLE 47 NORTH AMERICA: MARKET, BY FUNCTIONALITY, 2020–2027
             12.2.1 US
                        12.2.1.1 The US is the largest market in North America for patient engagement solutions in 2022
                                     TABLE 48 US: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2020–2027
                                     TABLE 49 US: MARKET, BY DELIVERY MODE, 2020–2027
                                     TABLE 50 US: MARKET, BY END USER, 2020–2027
                                     TABLE 51 US: MARKET, BY APPLICATION, 2020–2027
                                     TABLE 52 US: MARKET, BY THERAPEUTIC AREA, 2020–2027
             12.2.2 CANADA
                        12.2.2.1 Growing need for cost containment to propel the market growth in Canada
                                     TABLE 53 CANADA: MARKET, BY COMPONENT, 2020–2027
                                     TABLE 54 CANADA: MARKET, BY DELIVERY MODE, 2020–2027
                                     TABLE 55 CANADA: MARKET, BY END USER, 2020–2027
                                     TABLE 56 CANADA: MARKET, BY APPLICATION, 2020–2027
                                     TABLE 57 CANADA: MARKET, BY THERAPEUTIC AREA, 2020–2027
     12.3 EUROPE
             TABLE 58 EUROPE: MARKET, BY COUNTRY, 2020–2027
             TABLE 59 EUROPE: MARKET, BY COMPONENT, 2020–2027
             TABLE 60 EUROPE: MARKET, BY DELIVERY MODE, 2020–2027
             TABLE 61 EUROPE: MARKET, BY END USER, 2020–2027
             TABLE 62 EUROPE: MARKET, BY APPLICATION, 2020–2027
             TABLE 63 EUROPE: MARKET, BY THERAPEUTIC AREA, 2020–2027
             TABLE 64 EUROPE: MARKET, BY FUNCTIONALITY, 2020–2027
             12.3.1 GERMANY
                        12.3.1.1 Germany is the largest market for patient engagement solutions in Europe in 2022
                                     TABLE 65 GERMANY: MARKET, BY COMPONENT, 2020–2027
                                     TABLE 66 GERMANY: MARKET, BY DELIVERY MODE, 2020–2027
                                     TABLE 67 GERMANY: MARKET, BY END USER, 2020–2027
                                     TABLE 68 GERMANY: MARKET, BY APPLICATION, 2020–2027
                                     TABLE 69 GERMANY: MARKET, BY THERAPEUTIC AREA, 2020–2027
             12.3.2 FRANCE
                        12.3.2.1 Digital health insurance startups in France to drive the market growth for patient engagement solutions
                                     TABLE 70 FRANCE: MARKET, BY COMPONENT, 2020–2027
                                     TABLE 71 FRANCE: MARKET, BY DELIVERY MODE, 2020–2027
                                     TABLE 72 FRANCE: MARKET, BY END USER, 2020–2027
                                     TABLE 73 FRANCE: MARKET, BY APPLICATION, 2020–2027
                                     TABLE 74 FRANCE: MARKET, BY THERAPEUTIC AREA, 2020–2027
             12.3.3 UK
                        12.3.3.1 Favorable government initiatives to promote healthcare to support market growth in the UK
                                     TABLE 75 UK: MARKET, BY COMPONENT, 2020–2027
                                     TABLE 76 UK: MARKET, BY DELIVERY MODE, 2020–2027
                                     TABLE 77 UK: MARKET, BY END USER, 2020–2027
                                     TABLE 78 UK: MARKET, BY APPLICATION, 2020–2027
                                     TABLE 79 UK: MARKET, BY THERAPEUTIC AREA, 2020–2027
             12.3.4 SPAIN
                        12.3.4.1 Data security concerns restrict the market growth in Spain
                                     TABLE 80 SPAIN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2020–2027
                                     TABLE 81 SPAIN: MARKET, BY DELIVERY MODE, 2020–2027
                                     TABLE 82 SPAIN: MARKET, BY END USER, 2020–2027
                                     TABLE 83 SPAIN: MARKET, BY APPLICATION, 2020–2027
                                     TABLE 84 SPAIN: MARKET, BY THERAPEUTIC AREA, 2020–2027
             12.3.5 ITALY
                        12.3.5.1 The growing burden of chronic diseases in Italy drives the demand for patient engagement solutions
                                     TABLE 85 ITALY: MARKET, BY COMPONENT, 2020–2027
                                     TABLE 86 ITALY: MARKET, BY DELIVERY MODE, 2020–2027
                                     TABLE 87 ITALY: MARKET, BY END USER, 2020–2027
                                     TABLE 88 ITALY: MARKET, BY APPLICATION, 2020–2027
                                     TABLE 89 ITALY: MARKET, BY THERAPEUTIC AREA, 2020–2027
             12.3.6 REST OF EUROPE (ROE)
                        TABLE 90 ROE: MARKET, BY COMPONENT, 2020–2027
                        TABLE 91 ROE: MARKET, BY DELIVERY MODE, 2020–2027
                        TABLE 92 ROE: MARKET, BY END USER, 2020–2027
                        TABLE 93 ROE: MARKET, BY APPLICATION, 2020–2027
                        TABLE 94 ROE: MARKET, BY THERAPEUTIC AREA, 2020–2027
     12.4 ASIA PACIFIC
             FIGURE 21 ASIA PACIFIC: MARKET SNAPSHOT
             TABLE 95 ASIA PACIFIC: MARKET, BY COUNTRY, 2020–2027
             TABLE 96 ASIA PACIFIC: MARKET, BY COMPONENT, 2020–2027
             TABLE 97 ASIA PACIFIC: MARKET, BY DELIVERY MODE, 2020–2027
             TABLE 98 ASIA PACIFIC: MARKET, BY END USER, 2020–2027
             TABLE 99 ASIA PACIFIC: MARKET, BY APPLICATION, 2020–2027
             TABLE 100 ASIA PACIFIC: MARKET, BY THERAPEUTIC AREA, 2020–2027
             TABLE 101 ASIA PACIFIC: MARKET, BY FUNCTIONALITY, 2020–2027
             12.4.1 JAPAN
                        12.4.1.1 The rising geriatric population in Japan supports the market growth for patient engagement solutions
                                     TABLE 102 JAPAN: MARKET, BY COMPONENT, 2020–2027
                                     TABLE 103 JAPAN: MARKET, BY DELIVERY MODE, 2020–2027
                                     TABLE 104 JAPAN: MARKET, BY END USER, 2020–2027
                                     TABLE 105 JAPAN: MARKET, BY APPLICATION, 2020–2027
                                     TABLE 106 JAPAN: MARKET, BY THERAPEUTIC AREA, 2020–2027
             12.4.2 CHINA
                        12.4.2.1 Implementation of EMR solutions in healthcare by the Chinese government is expected to drive the demand for patient engagement solutions
                                     TABLE 107 CHINA: MARKET, BY COMPONENT, 2020–2027
                                     TABLE 108 CHINA: MARKET, BY DELIVERY MODE, 2020–2027
                                     TABLE 109 CHINA: MARKET, BY END USER, 2020–2027
                                     TABLE 110 CHINA: MARKET, BY APPLICATION, 2020–2027 USD MILLION)
                                     TABLE 111 CHINA: MARKET, BY THERAPEUTIC AREA, 2020–2027
             12.4.3 INDIA
                        12.4.3.1 High burden of chronic diseases to support the market growth for patient engagement solutions
                                     TABLE 112 INDIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2020–2027
                                     TABLE 113 INDIA: MARKET, BY DELIVERY MODE, 2020–2027
                                     TABLE 114 INDIA: MARKET, BY END USER, 2020–2027
                                     TABLE 115 INDIA: MARKET, BY APPLICATION, 2020–2027
                                     TABLE 116 INDIA: MARKET, BY THERAPEUTIC AREA, 2020–2027
             12.4.4 REST OF ASIA PACIFIC (ROAPAC)
                        TABLE 117 ROAPAC: MARKET, BY COMPONENT, 2020–2027
                        TABLE 118 ROAPAC: MARKET, BY DELIVERY MODE, 2020–2027
                        TABLE 119 ROAPAC: MARKET, BY END USER, 2020–2027
                        TABLE 120 ROAPAC: MARKET, BY APPLICATION, 2020–2027
                        TABLE 121 ROAPAC: MARKET, BY THERAPEUTIC AREA, 2020–2027
     12.5 REST OF THE WORLD
             TABLE 122 REST OF THE WORLD: MARKET, BY REGION, 2020–2027
             TABLE 123 ROW: MARKET, BY COMPONENT, 2020–2027
             TABLE 124 ROW: MARKET, BY DELIVERY MODE, 2020–2027
             TABLE 125 ROW: MARKET, BY END USER, 2020–2027
             TABLE 126 ROW: MARKET, BY APPLICATION, 2020–2027
             TABLE 127 ROW: MARKET, BY THERAPEUTIC AREA, 2020–2027
             TABLE 128 ROW: MARKET, BY FUNCTIONALITY, 2020–2027
             12.5.1 LATIN AMERICA
                        12.5.1.1 Developments in healthcare infrastructure to support the market growth
                                     TABLE 129 LATIN AMERICA: MARKET, BY COMPONENT, 2020–2027
                                     TABLE 130 LATIN AMERICA: MARKET, BY DELIVERY MODE, 2020–2027
                                     TABLE 131 LATIN AMERICA: MARKET, BY END USER, 2020–2027
                                     TABLE 132 LATIN AMERICA: MARKET, BY APPLICATION, 2020–2027
                                     TABLE 133 LATIN AMERICA: MARKET, BY THERAPEUTIC AREA, 2020–2027
             12.5.2 MIDDLE EAST & AFRICA
                        12.5.2.1 Rising government support to drive the market growth for patient engagement solutions in the MEA
                                     TABLE 134 MIDDLE EAST & AFRICA: MARKET, BY COMPONENT, 2020–2027
                                     TABLE 135 MIDDLE EAST & AFRICA: MARKET, BY DELIVERY MODE, 2020–2027
                                     TABLE 136 MIDDLE EAST & AFRICA: MARKET, BY END USER, 2020–2027
                                     TABLE 137 MIDDLE EAST & AFRICA: MARKET, BY APPLICATION, 2020–2027
                                     TABLE 138 MIDDLE EAST & AFRICA: MARKET, BY THERAPEUTIC AREA, 2020–2027

13 COMPETITIVE LANDSCAPE (Page No. - 150)
     13.1 OVERVIEW
     13.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
             13.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN THE PATIENT ENGAGEMENT SOLUTIONS MARKET
     13.3 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS
             FIGURE 22 REVENUE ANALYSIS OF KEY PLAYERS IN THE GLOBAL MARKET
     13.4 MARKET RANKING
             FIGURE 23 GLOBAL MARKET RANKING, BY KEY PLAYER, 2021
     13.5 COMPETITIVE BENCHMARKING
             TABLE 139 GLOBAL MARKET: COMPETITIVE BENCHMARKING OF KEY PLAYERS
             TABLE 140 GLOBAL MARKET: DETAILED LIST OF KEY STARTUP/SMES
     13.6 COMPETITIVE LEADERSHIP MAPPING
             13.6.1 STARS
             13.6.2 EMERGING LEADERS
             13.6.3 PERVASIVE PLAYERS
             13.6.4 PARTICIPANTS
                        FIGURE 24 GLOBAL MARKET (GLOBAL) COMPANY EVALUATION MATRIX, 2021
     13.7 COMPETITIVE LEADERSHIP MAPPING – START-UP/SME
             13.7.1 PROGRESSIVE COMPANIES
             13.7.2 STARTING BLOCKS
             13.7.3 RESPONSIVE COMPANIES
             13.7.4 DYNAMIC COMPANIES
                        FIGURE 25 COMPETITIVE LEADERSHIP MAPPING, START-UP/SME MATRIX MARKET
     13.8 COMPETITIVE SITUATIONS AND TRENDS
             13.8.1 PRODUCT LAUNCHES
             13.8.2 DEALS

14 COMPANY PROFILES (Page No. - 166)
     14.1 KEY PLAYERS
(Business Overview, Products Offered,

Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))* 
             14.1.1 IBM
                        TABLE 141 IBM: BUSINESS OVERVIEW
                        FIGURE 26 IBM: COMPANY SNAPSHOT (2021)
             14.1.2 MCKESSON CORPORATION
                        TABLE 142 MCKESSON CORPORATION: BUSINESS OVERVIEW
                        FIGURE 27 MCKESSON CORPORATION: COMPANY SNAPSHOT (2021)
             14.1.3 ALLSCRIPTS HEALTHCARE SOLUTIONS INC
                        TABLE 143 ALLSCRIPTS HEALTHCARE SOLUTIONS INC: BUSINESS OVERVIEW
                        FIGURE 28 ALLSCRIPTS HEALTHCARE, LLC: COMPANY SNAPSHOT (2021)
             14.1.4 ATHENAHEALTH
                        TABLE 144 ATHENAHEALTH: BUSINESS OVERVIEW
             14.1.5 ORION HEALTH
                        TABLE 145 ORION HEALTH: BUSINESS OVERVIEW
             14.1.6 CERNER CORPORATION
                        TABLE 146 CERNER: BUSINESS OVERVIEW
                        FIGURE 29 CERNER CORPORATION: COMPANY SNAPSHOT (2021)

                        TABLE 147 GETWELL NETWORK INC: BUSINESS OVERVIEW
             14.1.8 LINCOR SOLUTIONS
                        TABLE 148 LINCOR SOLUTIONS: BUSINESS OVERVIEW
             14.1.9 COGNIZANT
                        TABLE 149 COGNIZANT: BUSINESS OVERVIEW
                        FIGURE 30 COGNIZANT: COMPANY SNAPSHOT (2020)
             14.1.10 HARRIS HEALTHCARE
                        TABLE 150 HARRIS HEALTHCARE: BUSINESS OVERVIEW
     14.2 OTHER KEY PLAYERS
             14.2.1 GET REAL HEALTH
             14.2.2 ONEVIEW HEALTHCARE
             14.2.3 ADVANCEDMD
             14.2.4 EPIC SYSTEMS CORPORATION
             14.2.5 MEDITECH
             14.2.6 KAREO
             14.2.7 ECLINICAL WORKS
             14.2.8 WELLSTACK
             14.2.9 IQVIA
             14.2.10 VIVIFY HEALTH
             14.2.11 MEDHOST
             14.2.12 VALIDIC
             14.2.13 CUREMD HEALTHCARE
             14.2.14 MEDISYSINC.COM
             14.2.15 PATIENTPOINT, LLC
*Details on Business Overview, Products Offered,

Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies. 

15 APPENDIX (Page No. - 204)
     15.1 DISCUSSION GUIDE
     15.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
     15.3 AVAILABLE CUSTOMIZATIONS
     15.4 RELATED REPORTS
     15.5 AUTHOR DETAILS

    This market research study involved the extensive use of secondary sources, directories, and databases to identify and collect information useful for this technical, market-oriented, and financial study of the Patient Engagement Solutions market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify critical qualitative and quantitative information and to assess market prospects. The size of the patient engagement solutions market was estimated through various secondary research approaches and triangulated with inputs from primary research to arrive at the final market size.

    Secondary Research

    The secondary sources referred to for this research study include publications from government sources, such as WHO, ATA, AHA and AAHM. Secondary sources also include corporate and regulatory filings (such as annual reports, SEC filings, investor presentations, and financial statements); business magazines and research journals; press releases; and trade, business, and professional associations. Secondary data was collected and analyzed to arrive at the overall size of the global patient engagement solutions market, which was validated through primary research.

    Primary Research

    Extensive primary research was conducted after acquiring basic knowledge about the global patient engagement solutions market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand side (such as Individual Physicians, Physician Groups, Hospitals, Clinics and Other Healthcare Facilities, Payers- Private and Public Insurance Bodies, Other End Users- Employer Groups and Government Bodies) and supply-side (such as C-level and D-level executives, product managers, marketing and sales managers of key manufacturers, distributors, and channel partners, among others) across five major regions—North America, Europe, the Asia Pacific, Latin America, Middle East and the Africa. Approximately 70% and 30% of primary interviews were conducted with supply-side and demand-side participants, respectively. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.

    Patient Engagement Solutions Market Size

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    Both top-down and bottom-up approaches were used to estimate and validate the total size of the global patient engagement solutions market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

    • The key players in the industry and markets have been identified through extensive secondary research.
    • The revenue generated from the sale of patient engagement solutions products by leading players has been determined through primary and secondary research.
    • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

    Data Triangulation

    After arriving at the overall market size, from the market size estimation process explained above, the patient engagement solutions market was split into segments and subsegments. To complete the overall market engineering process and to arrive at the exact statistics for all segments and subsegments, the data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the remote patient monitoring market

    Report Objectives

    • To define, describe, and forecast the global patient engagement solutions market based on component, delivery mode, application, therapeutic area, functionality, end user, and region
    • To provide detailed information regarding the major factors (such as drivers, restraints, opportunities, and challenges) influencing the market growth
    • To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall patient engagement solutions market
    • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
    • To strategically analyze the market structure and profile the key players of the patient engagement solutions market and comprehensively analyze their core competencies
    • To forecast the size of the market segments with respect to four regions, namely, North America, Europe, Asia Pacific, and the Rest of the World (Latin America and the Middle East & Africa)
    • To track and analyze competitive developments such as product launches, acquisitions, partnerships, agreements, and collaborations in the patient engagement solutions market during the forecast period

    Available Customizations:

    With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

    Company information

    • Detailed analysis and profiling of additional market players (up to 20)
    Report Code
    HIT 2767
    Published ON
    May, 2022
    Choose License Type
    BUY NOW
    • SHARE
    X
    Request Customization
    Speak to Analyst
    Speak to Analyst
    OR FACE-TO-FACE MEETING
    PERSONALIZE THIS RESEARCH
    • Triangulate with your Own Data
    • Get Data as per your Format and Definition
    • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
    • Any level of Personalization
    REQUEST A FREE CUSTOMIZATION
    LET US HELP YOU!
    • What are the Known and Unknown Adjacencies Impacting the Patient Engagement Solutions Market
    • What will your New Revenue Sources be?
    • Who will be your Top Customer; what will make them switch?
    • Defend your Market Share or Win Competitors
    • Get a Scorecard for Target Partners
    CUSTOMIZED WORKSHOP REQUEST
    +1-888-600-6441
    • Call Us
    • +1-888-600-6441 (Corporate office hours)
    • +1-888-600-6441 (US/Can toll free)
    • +44-800-368-9399 (UK office hours)
    CONNECT WITH US
    ABOUT TRUST ONLINE
    ©2022 MarketsandMarkets Research Private Ltd. All rights reserved
    DMCA.com Protection Status Website Feedback